Skip to main content

Artificial Pancreas Market Application Evaluation, Focus On Key Drivers and Global Foresight To 2023

Artificial Pancreas Market Global Opportunity Analysis by control type (threshold suspend device system, non-threshold suspend device system, control-to-range (CTR) system, and control-to-target (CTT) system) by treatment type (insulin only, bi-hormonal, hybrid) and by end users, Technology, Trends, Size, Share and Growth By Top Leaders – Forecast till 2023.
Artificial pancreas is a medical device that mimics the glucose-regulating function of a healthy pancreas with little or no input from the patient. These devices use a computer-controlled algorithm which enables it to precisely calculate the amount of insulin needed to be delivered with the use of an insulin infusion pump. The Global Artificial Pancreas Market Share is expected to reach $ 360 million by the end of 2023, this market is projected to growing at a CAGR of ~ 15.2 % during 2017-2023.
Top Key players:
Some of the top Key players profiled in this Research Study are Johnson & Johnson, Medtronic, Beta Bionics, Semma Therapeutics Bigfoot Biomedical, Admetsys (pipeline product analysis), Animas Corporation, Medtronic, Defymed, dexcom, Insulet, medtech, Tandem Diabetes Care, TypeZero Technologies, and others.
Global Artificial Pancreas Market Segmental Analysis
The market is segmented on the basis of type, treatment type, end users, and region.
the artificial pancreas market Based on type segmented as threshold suspend device system, non-threshold suspends device system, control-to-target (CTT) system, and control-to-range (CTR) system.
the artificial pancreas market Based on the treatment type segmented as insulin only, bi-hormonal, and hybrid.
the global artificial pancreas market Based on end users is segmented as hospitals and clinics, research, and others.
the global artificial pancreas market Based on the region segmented into North America and South America, Europe, Asia Pacific, and the Middle East and Africa.
Study objectives:
  • To provide a detailed analysis of the market structure along with estimated future growth forecast for the next six years about various segments and sub-segments of the global Artificial Pancreas market.
  • To provide insights about factors affecting the market growth.
  • To analyze the global Artificial Pancreas market based on various factors – Price Analysis, Supply Chain Analysis, Porters Five Force analysis etc.
  • To provide past and estimated future revenue of the market’s segments and sub-segments with respect to four main geographies and their countries – the Americas, Europe, Asia Pacific along with Middle East & Africa.
  • To provide country level analysis of the market with respect to the current market size and future growth prospects.
  • To provide country level analysis of the market which includes segmentation by type, treatment type and end users.
  • To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape of the market.
  • To track and analyze developments which are competitive in nature such as joint ventures, strategic alliances, mergers and acquisitions, new product developments along with research and developments that are currently taking place in the global artificial pancreas markets.
TABLE OF CONTENTS:
  1. INTRODUCTION
  2. RESEARCH METHODOLOGY
  3. MARKET DYNAMICS
  4. MARKET FACTOR ANALYSIS
  5. GLOBAL ARTIFICIAL PANCREAS MARKET, BY CONTROL TYPE
5.1 THRESHOLD SUSPEND DEVICE SYSTEM
5.2 NON-THRESHOLD SUSPEND DEVICE SYSTEM
5.3 CONTROL-TO-RANGE (CTR) SYSTEM
5.4 CONTROL-TO-TARGET (CTT) SYSTEM
  1. GLOBAL ARTIFICIAL PANCREAS MARKET, BY TREATMENT TYPE
6.1 INSULIN ONLY
6.2 BI-HORMONAL
6.3 HYBRID
  1. GLOBAL ARTIFICIAL PANCREAS MARKET, BY END USERS
7.1 HOSPITALS AND CLINICS
7.2 RESEARCH
7.3 OTHERS
  1. GLOBAL ARTIFICIAL PANCREAS MARKET, BY REGION
8.1 NORTH AMERICA
8.1.1 INTRODUCTION
8.2 EUROPE
8.2.1 INTRODUCTION
8.3 ASIA-PACIFIC
8.3.1 INTRODUCTION
8.4 MIDDLE EAST & AFRICA
8.4.1 INTRODUCTION
  1. COMPETITIVE LANDSCAPE
9.1 MAJOR STRATEGIES ADOPTED BY MARKET PLAYERS
9.1.1 STRATEGIC PARTNERSHIP
9.1.2 MERGER & ACQUISITION
  1. COMPANY PROFILE
10.1 MEDTRONIC
10.1.1 OVERVIEW
10.1.2 PRODUCT OVERVIEW
10.1.3 FINANCIALS
10.1.4 KEY DEVELOPMENTS
10.2 JOHNSON & JOHNSON
10.2.1 OVERVIEW
10.2.2 PRODUCT OVERVIEW
10.2.3 FINANCIALS
Continued…
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312

Comments

Popular posts from this blog

Hemifacial Spasm Market Application Scope, Types, Technology Benefits and Global Business

  Hemifacial Spasm Market  Research Information: By Diagnosis (Mri, Ct Or Cat Scan, Angiography (Arteriography)), Treatment (Medical Treatment, Surgical Treatment, Combinational Therapy, Tens, Physical Therapy, Others), End User – Global Forecast Till 2023 Market Highlights: Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population. A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market. However, difficult diagnosis, cost of treatment, side-effect...

U.S. Uterine Fibroid Market Latest Devices, Key Players Statistics Data, Regional Business Outlook 2022

U.S. Uterine Fibroid Market by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The  US Uterine Fibroid Market  report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. These are the Top Market...

Global Merkel Cell Carcinoma Market Clincial Assessment and Professional Industry Outlook 2023

  Global Merkel Cell Carcinoma Market  Research Report: By Diagnosis (Physical Examination, Sentinel Node Biopsy, Imaging Test), Treatment (Surgery, Radiation Therapy, Chemotherapy), End User (Hospitals & Clinics, Diagnostic Centers) – Forecast till 2023 Market Highlights Increasing prevalence of Merkel cell carcinoma and growing geriatric population are estimated to be the major drivers for the market growth during the forecast period. Moreover, increasing R&D expenses by the key market players, rising mortality rate by MCC, and growing healthcare expenditure is further boosting the market growth. However, the high cost of therapeutics and related side effects along with the lack of awareness and low per capita healthcare expenditures in the developing economies restrains the market growth.  Intended Audience Pharmaceutical Companies Biotechnological Institutes Government and Private Laboratories Research and Development (R&D) Companies Medical Research Labor...